What's Happening?
The National Comprehensive Cancer Network (NCCN) has announced the appointment of Dr. Nancy L. Lewis as its new Chief Scientific Officer. Dr. Lewis, an accomplished biomedical researcher, will oversee NCCN's programs aimed at advancing clinical trials
and improving cancer care quality. Her previous roles include Senior Clinical Program Leader at Novartis Pharmaceuticals and Associate Professor at various academic cancer centers. Dr. Lewis will be responsible for guiding the NCCN Oncology Research Program and contributing to the development of the NCCN Clinical Practice Guidelines in Oncology.
Why It's Important?
Dr. Lewis's appointment is significant for the NCCN as it continues to play a crucial role in setting standards for cancer care and research. Her leadership is expected to enhance the organization's efforts in clinical trials and cancer treatment guidelines, potentially leading to improved patient outcomes. The NCCN's work is vital in the fight against cancer, as it provides evidence-based guidelines that influence treatment protocols worldwide. Dr. Lewis's expertise in clinical trials and her leadership in biomedical research will likely drive innovation and progress in oncology.
